Serogroup W-135 meningococcal disease among travelers returning from Saudi Arabia - United states, 2000

Morbidity and Mortality Weekly Report

Volumn 49, Issue 16, 2000, Pages 345-346

  Fine, A ^b   Layton, M ^b   Hakim, A ^a  

^a MAIMONIDES MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN; ISOLATION AND PURIFICATION; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; SAUDI ARABIA; SEROTYPING; TRAVEL; UNITED STATES;

HUMANS; MENINGOCOCCAL INFECTIONS; NEISSERIA MENINGITIDIS; SAUDI ARABIA; SEROTYPING; TRAVEL; UNITED STATES;

EID: 0034724544     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. World Health Organization. Meningococcal disease in France, United Kingdom, Oman, Saudi Arabia, Netherlands. Available at http://www.who.int/emc/outbreak_news/n2000/April/ 21a%20apr2000.html. Accessed April 25, 2000.
2. Rosenstein NE, Perkins BA, Stephens DS, et al. The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis 1999; 180:1894-901.
3. Moore PS, Harrison LH, Teizak EE, Ajello GW, Broome CV. Group A meningococcal carriage in travelers returning from Saudi Arabia. JAMA 1988;260:2686-9.
4. CDC. Meningococcal disease among travelers returning from Saudi Arabia. MMWR 1987;36:559.
5. CDC. Control and prevention of serogroup C meningococcal disease: evaluation and management of suspected outbreaks: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997;46(no. RR-5):13-21.